Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Clinova sponsors health professional ‘olympics’

Manufacturer Clinova has sponsored an Olympic-style competition between healthcare professionals.

 

Clinova’s ORS hydration tablets would be the “official hydration partner” of the 36th annual World Medigames in Limerick, it said. The games, which take place from July 18-25, will involve doctors, nurses and pharmacists from 40 countries “competing in the Olympic spirit”, Clinova said.

 

Clinova and medicines distributor Pharmed UK would also sponsor a session on sports hydration at the Sports Medicine International Symposium, taking place alongside the games, it said.

 

ORS hydration tablets come in lemon, blackcurrant and strawberry flavours. The soluble tablets were gluten- and lactose-free and suitable for vegetarians, Clinova added.

 

A pack of 12 tablets retails at £4.99 and a pack of 24 tablets at £6.99.

 

To order, contact 0845 652 5063

Topics

         
Registrant member of the Assurance and Appointments Committee 
Nationwide
£ Renumeration

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD007561

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel